GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: BMS-986397 | BMS986397 | CC-91633 [3] | CC91633 | compound 173 [WO2020243379] | example 25 [WO2020243379]
Compound class:
Synthetic organic
Comment: The chemical structure for this compound was obtained from WHO INN proposed list 134 (Feb 2026), in which it is described as a serine/threonine kinase degradation inducer with antineoplastic potential. A structure search in PubChem suggests that this is the INN for BMS-986397, a lead casein kinase 1α (CK1α) degrader [2]. Claimed in Celgene Corp. patent WO2020243379A1 [1]. Relzasertideg targets CK1α for CRL4CRBN E3 ubiquitin ligase-mediated degradation.
|
|
|||||||||||||||||||||||||||||||||||
| Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||